BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026

Apr 8, 2026 | BioStem in the News

POMPANO BEACH, Fla., April 08, 2026 (GLOBE NEWSWIRE) — BioStem Technologies® (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of perinatal tissue allograft products, today announced its...

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 31, 2026 | BioStem in the News

POMPANO BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that...

BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025

Mar 30, 2026 | BioStem in the News

POMPANO BEACH, Fla., March 30, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that...

BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 24, 2026 | BioStem in the News

POMPANO BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported...

BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair

Mar 23, 2026 | BioStem in the News

Pompano Beach, FL, March 23, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the appointment of Jodi...

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

Mar 11, 2026 | BioStem in the News

POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative medicine, today...